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Abstract
Smallpox is an infectious disease that is unique to humans, caused by a poxvirus. It is one of the most lethal of diseases; the virus variant
Variola major has a mortality rate of 30%. People surviving this disease have life-long consequences, but also assured immunity. Historically,
smallpox was recognized early in human populations. This led to prevention attempts—variolation, quarantine, and the isolation of infected
subjects—until Jenner’s discovery of the ﬁrst steps of vaccination in the 18th century. After vaccination campaigns throughout the 19th and
20th centuries, the WHO declared the eradication of smallpox in 1980. With the development of microscopy techniques, the structural
characterization of the virus began in the early 20th century. In 1990, the genomes of different smallpox viruses were determined; viruses
could be classiﬁed in order to investigate their origin, diffusion, and evolution. To study the evolution and possible re-emergence of this viral
pathogen, however, researchers can only use viral genomes collected during the 20th century. Cases of smallpox in ancient periods are
sometimes well documented, so palaeomicrobiology and, more precisely, the study of ancient smallpox viral strains could be an exceptional
opportunity. The analysis of poxvirus fragmented genomes could give new insights into the genetic evolution of the poxvirus. Recently, small
fragments of the poxvirus genome were detected. With the genetic information obtained, a new phylogeny of smallpox virus was described.
The interest in conducting studies on ancient strains is discussed, in order to explore the natural history of this disease.
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Introduction
Smallpox (variola) is an acute infectious disease of viral origin
(genus Orthopoxvirus) that has caused devastating epidemics.
During the 20th century, it was responsible for 300–500 mil-
lion deaths, and in the last millennium it is estimated to have
been responsible for 10% of deaths worldwide. Thus, it is
highly probable that this disease has strongly selected human
populations, but there is no current evidence to validate this
hypothesis. Following a global pandemic in the 18th century,
vaccination against smallpox began in the early 19th century,
and the last case was reported in Somalia in 1977. In 1980, the
WHO declared that smallpox had been eradicated. It is not
clear what role population selection and the general improve-
ment in hygiene conditions played in this eradication process,
but the extensive vaccination programme conducted by the
WHO certainly accelerated the process (www.who.int/csr/
disease/smallpox/en/). In the modern era, although populations
worldwide have been affected by smallpox, it is the isolated
non-occidental populations that have been affected the most;
some New World and Siberian populations have been
decimated by the virus.
Today, the study of smallpox has various challenges. (i)
Social and medical challenges: many populations living in
remote areas, where smallpox has become endemic only
recently, will migrate to live in urban or suburban environ-
ments. Thus, minor cases of the disease could result in
epidemics through the gradual reduction in the number of
vaccinated people, and the major environmental changes that
affect them. Moreover, humans constitute the only known
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reservoir of the virus, but the emergence of an animal
reservoir or a very closely related animal virus that could adapt
to humans is not excluded. Note that current animal poxvirus
strains can infect humans, but that virulence differs between
strains [1]. Governments must therefore control live strains of
the poxvirus (see below), and remain informed about the
hazards of the virus, its mutation potential during epidemics
(which can speed up the epidemic and/or make it last longer),
and the potential for competition between different strains. It
is also necessary to identify these strains, and to distinguish
between the natural re-emergence of the disease and its
genetic manipulation in the laboratory. This is also of
importance because smallpox could be developed for acts of
bioterrorism. (ii) It is also a biological challenge, owing to
co-evolution between humans and the environment. What
genes were selected by smallpox epidemics during human
evolution? How has the virus evolved? In human population
histories, what were the relationships between the major
human-killers (plague and tuberculosis) and smallpox?
Recently, we demonstrated a case of smallpox through
molecular analysis; an autochthonous subject who died in
Yakutia, Eastern Siberia (Fig. 1), between 1628 and 1640,
during a signiﬁcant tuberculosis epidemic [2]. On the basis of
small fragments of degraded DNA, we proposed a new
phylogeny of the virus. This research gave new perspectives on
the genetic study of smallpox; ancient smallpox samples are
now considered to be safe to work on, owing to the degraded
nature of their DNA. There is no doubt that the discovery of
ancient smallpox cases and the sequencing of ancient strains
will give further insights into the natural history of this disease.
FIG. 1. Location of Yakutia in Siberia.
Map of the three initial regions occupied
by ancient Yakut populations excavated
during MAFSO archaeological campaigns.
The star shows the location of the
shamanic tree grave, © Patrice Gerard
CNRS.
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Clinical Symptoms and Epidemiology
Humans are the only known hosts or reservoirs of smallpox.
Smallpox is one of the most feared diseases in the world, as its
mortality rate ranges from 1% for cases of Variola minor, to
>97% for haemorrhagic smallpox cases in unvaccinated
subjects. The incubation period of 8–14 days is followed by a
virus-like invasion phase (high fever, shivering, and arthralgia),
and then by a state phase with a maculopapular rash, which
produces blisters on the third day and infected pustules on the
seventh day. If the subject survives, there is a drying phase on
the 10–12th days, when the scabs fall off to leave permanent
scars. The patient will then be immunized, but the duration of
this immunization period is still debated [3]. With the
haemorrhagic form, the subject dies after the ﬁrst 24 h of
the invasion phase, following bleeding from the skin and/or
mucous membranes. During the 19th century, less virulent
smallpox epidemics were recorded, with a death rate of 1% in
South Africa and Central America, where the less virulent
smallpox is known as alastrim [4]. The mode of disease
transmission is usually direct contact: the virus is transmitted
primarily by the exhalation of patients, and then by contact
with skin lesions. The virus is very stable, and can survive for
years in the scabs [5]. In natural conditions, however, the virus
remains pathogenic for a couple of weeks.
The earliest and most incontestable descriptions of small-
pox appeared in the fourth century in China, and then later in
India (seventh century) and in Southwest Asia and the
Mediterranean (tenth century) [4]. It was prevalent in south-
ern Europe during the 13th century, when it started to spread
throughout Europe, causing millions of deaths over the
centuries [6,7]. In the 18th century, smallpox was endemic in
Europe, and signiﬁcant peaks in the number of deaths were
observed—14 000 in 1716, 20 000 in 1723 and 14 000 in 1796
in Paris [9]—killing 10% of newborns and one in three adult
patients. It decimated Amerindian populations during the
conquest of the New World from the beginning of the 16th
century [4], and it was the succession of smallpox epidemics
and other infectious diseases imported from the Old World
that destroyed what remained of the Inca culture [8].
Owing to its distinctive clinical symptoms, smallpox has
been known as a disease ‘entity’ for many centuries.
Campaigns against smallpox began in the absence of current
scientiﬁc knowledge, while the causes and mechanisms of the
disease were unknown. There were attempts to develop
various methods to protect against smallpox. The earliest
methods, reported in the tenth century, were insufﬂation in
China and cutaneous inoculation in India [4]. Variolation, to
avoid serious smallpox, consists of an inoculation with ‘benign
smallpox’ from the pustules of a patient. The origin of this
technique is disputed, but it is known to have been practised in
China in the 16th century. It was imported into the West in
the early 18th century by Lady Wortley Montagu, the wife of
the Ambassador of Great Britain to Turkey [10], but it is likely
that different techniques had existed previously in the
European countryside. In Scotland, farmers attached wool
soaked in smallpox pus to their wrists, and in some Italian
mountain areas children were made to wear similarly soaked
shirts [11,12]. The results were, however, very random, and
many subjects still died, despite these attempts at variolation.
The practice was introduced into France in the second half of
the 17th century, where it was extensively studied and ﬁercely
debated (owing to the dangers of inoculation), with written
submissions to the Academy of Sciences [4]. Before 1760,
European doctors replaced the needle (used in Turkey) with
the lancet, which allowed doctors to make a deeper cut [13],
but these incisions were either ineffective or catastrophic.
After 1760, Sutton proposed a method involving a more
superﬁcial incision, increasing the reliability of the inoculation
and hence its popularity [12].
From 1769, at least six people in England and Germany
successfully tested the possibility of using the cowpox vaccine
against smallpox in humans [4]. At the end of the 18th century,
Edward Jenner, a country doctor in England with many farmer
patients, noted that contact with livestock, particularly cows,
exposed farmers to a disease that was transmissible to humans
—cowpox or vaccinia, the smallpox of cows. From the
observation that milkmaids who had contracted cowpox did
not usually contract smallpox, Jenner postulated that the pus
present in the cowpox vesicles protected people against
smallpox. Today, we know that cowpox vaccine causes a
benign disease in humans, in comparison with smallpox, but at
the time it seemed that a convergence of ideas led to replacing
the pus of smallpox with that of cowpox.
In 1796, Jenner developed the ﬁrst stages of the vaccination
process: he inoculated a child with the pus from the hand of a
farm worker who was infected with cowpox (via contact with
the infected cow’s udders), causing a localized infection at the
inoculation site. Threemonths later, he inoculated the child with
smallpox; the child showed no signs of infection, and so was
immunized against the virus [4]. Over a period of 20 years,
Jenner conducted systematic experiments that led to the
establishment of the vaccination method, which replaced
inoculation. It should be noted, however, that, at the same time
as variolation and vaccination, procedures were being used in
Europe, the quarantine and isolation of affected individuals,
which also reduced the spread of the disease [14,15].
In the early 19th century, vaccination against smallpox
spread rapidly throughout the occidental world [16], and was
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largely responsible for the observed change in world demog-
raphy. World demography before vaccination is termed
pre-Jenner; in the course of several generations, for 1000
births, one-third of subjects died between birth and the age of
1 year, and one-third between 1 year and 18 years of age.
World demography after vaccination is termed post-Jenner; an
increase in the number of surviving subjects between birth and
18 years of age is observed. If birth rates remain constant,
there is a population explosion, and this is what occurred in
Europe in the 19th century because of vaccination. The world
population increased to approximately 1 billion in 1800, and to
>1.5 billion in 1900 [17]. The ﬁrst vaccination campaigns,
carried out in the ﬁrst half of the 20th century, and the WHO
screening programme conducted from 1967 onwards were
highly successful, and smallpox was declared to be eradicated
in 1980 (the last reported case was in 1977 [4].
Initial Isolation and Characterization of the
Smallpox Viruses
The disease was recognized and measures for its prevention
were initiated early in human history (16th century in China),
but investigations into the virus itself did not begin until the
late 19th century, with the establishment of the new science of
virology. Virus particles of smallpox, cowpox and vaccinia were
ﬁrst identiﬁed under the microscope, and then by electron
microscopy (before any other viruses had been visualized), and
their chemical compositions were analysed before those of
animal viruses [4]. Most studies and knowledge on ortho-
poxviruses were based on the vaccinia virus.
The ﬁrst reports of studies on the viral elements of vaccinia
using microscopy were in 1886 by Buist [18] and Cal-
mette-Guerin in 1901 [19], who observed many elementary
particles in the stained smears and vaccine lymph of rabbits.
Prowazek in 1905 and Paschen in 1906 [4] also showed these
‘elementary bodies’ by using different microscopy methods. It
was, however, the work of Ledingham in 1931 [20] that
demonstrated deﬁnitively that the elementary bodies were
indeed the infectious entities in the lymph. Thereafter, analysis
of the pox virion structure was dependent on the power of
electron microscopy. Between 1948 and 1970, thin sections of
infected cells were used to characterize the membrane
structures, core and components of the vaccinia virus [4].
The presence of DNA in the virus, but not RNA, was
demonstrated in 1940 [21,22]. In 1962, the double-stranded
nature of the virus DNA and its guanine and cytosine
composition was demonstrated [23]. The ﬁrst genomic
sequences of the smallpox virus were published in the early
1990s, with the complete DNA sequence of the vaccinia virus
[24,25]. Thereafter, a signiﬁcant effort was made to sequence
most of the isolates that had been collected during the WHO
Intensiﬁed Smallpox Eradication Programme (1967–1980).
Currently, approximately 50 genomes of human poxviruses,
as well as those of dozens of animal poxviruses, are available
on the web (http://www.poxvirus.org). Thus, new insights into
the origin, distribution and evolution of different human clades
have been obtained [26,27].
The Virus and its Evolution
Viruses of the genus Orthopoxvirus are widespread in verte-
brates, and most of them are species-speciﬁc [28,29]. The
best-studied members of the Orthopoxvirus are the poxviruses
(Poxviridae), DNA viruses that replicate in the cell cytoplasm
[30]. These include smallpox viruses (Variola major and
V. minor), the primate viruses (highly pathogenic to humans),
and the bovine poxvirus (used as a vaccine against the three
aforementioned viruses). The genome of an orthopoxvirus is a
linear double-stranded DNA molecule containing c. 200 genes.
The central region of the genome has highly conserved
sequences, and contains the majority of genes involved in
transcription, mRNA biosynthesis, DNA repair and replica-
tion, and the modiﬁcation of viral structural proteins [29,30].
The terminal regions are variable, and determine the speciﬁc
properties of the species, the strain of the virus, and its
immunomodulatory protein genes [31–33]. The virulence of
smallpox is related to a set of genes encoding proteins that
efﬁciently modulate (as compared with other viruses) the
multiple defence mechanisms of the host organisms [34].
Following the eradication of smallpox in 1980, two conser-
vatories holding the live viral strains were created: in the CDC
in Atlanta, USA, and VECTOR in Novosibirsk, the Russian
Federation. Although the purpose of these conservatories is
regularly discussed [35], their goal is to store live strains in
order to establish medical and vaccination strategies in the
event of the re-emergence or bioterrorism. Currently, they
store live smallpox strains that were collected between 1944
and 1977 [26,36]. Their genomes have been completely
sequenced and are open access (NCBI GenBank). These
strains follow the global phylogeographical distribution; the
ﬁrst cluster groups V. major strains from Asia, India, and Africa,
excluding the West, and the second cluster groups the two
subclusters of West Africa and South America.
Several studies on the strains are being conducted by the
WHO and authorized laboratories: tests for the diagnosis of
smallpox in the laboratory, smallpox genomic studies, the
establishment of animal models and of pathogenesis, and the
development of antivirals for the treatment of smallpox [37].
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Independent advisory experts assess all smallpox research
programmes [38]. With technological advances in
high-throughput sequencing and the generation of whole
genomes for modern strains, the origin of and variability in
virulence factors for these poxviruses are being well studied
with phylogenetic methods [26,36]. The evolution of different
smallpox viruses is being studied by the use of data on
sequence diversity, genome structure, and variation in coding
regions [27]. The evolution and phylogeny of poxviruses
speciﬁc to vertebrates are also being studied, to obtain a
better understanding of the dispersion and date of the origin of
these strains [39,40].
The published phylogenetic tree found a root/most recent
common ancestor (MRCA) for the sequences of AD 120
(maximum) (Fig. 2; mean estimate of AD 928 for the the MRCA
of all smallpox sequences; 5–95% conﬁdence range of AD 120
to AD 1714; median of AD 1585). This date is consistent with
that reported in early documents on smallpox (before AD 1000
[4]), but it is certainly very recent, considering when the
disease ﬁrst appeared (between 1500 BC and 1100 BC in China
and India [4]). Indeed, apart from the traditional descriptions
of the disease, interpretations of certain texts and/or archae-
ological discoveries suggest a much earlier existence of the
disease, especially in its cutaneous form. Typical rashes have
been identiﬁed in Egyptian mummies dating from 1100 BC to
1580 BC [4,41,42], and the disease could have struck China in
1122 BC and India in 1500 BC [4,42]. The divergence between
current phylogenies and archaeological evidence is related to
the fact that current strains represent only a small part of
smallpox genetic variability in the 20th century. This has
FIG. 2. Phylogenetic analysis of
concatenated sequences of an ancient
Siberian smallpox virus (PoxSib). These
three gene segments showed that the
300-year-old virus did not belong to the
cluster of known sequenced strains of the
20th century (1946–1977). Derived from
Fig. 1b in [2]. Reprinted with permission.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, 210–218
214 Clinical Microbiology and Infection, Volume 20 Number 3, March 2014 CMI
several implications: (i) as more strains are discovered,
variability increases, so it is probable that the MRCA is older
than present estimates suggest; and (ii) a large number of
strains have disappeared during human history, or they are not
detected today, because they are no longer virulent. Strains
affecting European and American human populations between
the 13th and 18th centuries have been eradicated since the
19th century, following the ﬁrst vaccination campaigns [7].
Palaeogenetic Studies
Palaeomicrobiology is a ﬁeld of research based on the
detection of infectious diseases in the past [43]. Fragments
of bacterial or viral DNA are searched for in possibly infected
tissues, or in the teeth of subjects, who died while they had
bacteraemia or viraemia, taking into account the speciﬁc
characteristics of the ancient DNA sample (Fig. 3). Regarding
smallpox, our work in Central Yakutia (Eastern Siberia) in
2004 led to the discovery of an elite burial (wealthy and
organized) dating from between 1730 and 1740, with ﬁve
remarkably well-preserved subjects (Fig. 4). The anatomical
study revealed no trauma, and the burial of subjects at the
same time during winter suggested that they had died during a
disease epidemic [44]. The search for pathogens was initially
focused on bacterial pathogens, but as none was found, a viral
origin was hypothesized. This was reinforced by the presence
of iron in the lung alveoli of the subject, suggesting death
resulting from a haemorrhage. Smallpox was not the ﬁrst virus
to be tested for, because none of the four subjects whose skin
could be examined showed any traces of blisters or pustules.
Only in the best-preserved subject were we able to identify
FIG. 3. Composition of environmental, undetermined and potential pathogenic 16S rDNA sequences in ancient skeletons and frozen bodies. The
majority of the bacterial pool comprised environmental bacteria originating from the soil, vegetation or permafrost characteristic of the Arctic.
Reproduced from Fig. 2 in [45]. Reprinted with permission. Palaeogenetic studies conducted over >10 years in our laboratory have clearly
demonstrated the persistence of fragmented DNA molecules [45,47]. It is important to note that such archaeological samples consist of many DNA
molecules, originating not only from the subject (human nuclear and mitochondrial DNA) and the pathogen potentially responsible for the death of
the subject (bacterial or viral DNA), but also environmental bacteria from this complex environment: soil, water, and plants. Metagenomic or
bacterial genome analyses show that the majority of bacteria in this kind of sample are environmental [45].
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three DNA fragments of the ancient human poxvirus by PCR
[2]. To assess the persistence of large DNA fragments, we
conducted long-range PCRs on the E9 l gene (coding for
polymerase), according to the method in [39]. The ampliﬁca-
tions expected were approximately 1000 bp and 2043 bp: no
positive results were obtained, suggesting a fragmented viral
genome [2]. The absence of pustules, the presence of a
pulmonary haemorrhage and the detection of the virus could
indicate that the subject had haemorrhagic smallpox. It would
be interesting to look for the presence of smallpox in the
other subjects in the grave (Fig. 4). The ﬁrst phylogenetic
study conducted on these fragments showed, as expected (see
above), that this ancient strain is distinct from the modern
strains described previously (Fig. 2).
This study was the ﬁrst of its kind—it opens up interesting
avenues for phylogenic and natural history approaches to
studying smallpox. The virus is considered to be resistant to
environmental conditions, but the subject was buried in
Central Yakutia, where temperatures can drop below 50°C
in winter (see conservation of burials and bodies in Fig. 5), and
a burial lasting two and a half centuries has destroyed the virus,
fragmenting and degrading its DNA. It is hoped that research
on archaeological samples will be facilitated in the future.
According to current legislation and risk assessments, the
theoretical level of containment required in a laboratory,
owing to the classiﬁcation of a parental strain, does not
necessarily need to be implemented. Smallpox and archaeo-
logical samples that are signiﬁcantly degraded are not patho-
genic. Thus, we can assume that a biosafety level of 2 would be
FIG. 4. Evocation of the shamanic tree grave, © Nicolas Senegas;
watercolour of different masks and capes of studied woman, ©
Christiane Petit-Hochstrassesr. The tomb is large and well organized,
which shows that the population and the related subjects had not all
been eradicated. It is interesting to note that the golden age in Yakutia
ends after 1728–1740 [44,46]. Originally, we discussed a major
economic change [44]; it would be interesting to determine how a
haemorrhagic smallpox epidemic could have participated in this
decline.
FIG. 5. The frozen graves of Yakutia: an exceptional conservation. From left to right: Shamanic tree (2004), Kouranakh (2011), Ordiogone 2
(2007), © Patrice Gerard CNRS; Eletche€ı 1 (2009), © Nicolas Senegas. The main ethnic group from this region, the Yakuts, used inhumation as a
common funerary practice from when they discovered the region in the Middle Ages [44]. This is unique to Yakuts in Siberia and the Arctic, and
provides a unique opportunity for continuous temporal sampling from the Middle Ages onwards.
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required in a laboratory, corresponding to the minimum level
required by the regulations for handling of samples of human
origin (e.g. teeth). The scientiﬁc community could then use the
‘smallpox model’ to assess the co-evolution of virulence and
resistance genes (if they exist in humans) in subjects buried
before, during and after an epidemic. The future of smallpox
natural history remains to be written; it will not be dangerous,
so the interest in keeping live strains of the virus is brought
into question again.
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